Andrew D. Zelenetz, MD, PhD

Vice Chair, Medical Informatics, Department of Medicine
Andrew D. Zelenetz, MD, PhD

I am a medical oncologist with special expertise in lymphoma, and former Chief of Memorial Sloan Kettering’s Lymphoma Service. I am a member of a close-knit team that provides compassionate, multidisciplinary care to patients with lymphoma.

I have helped develop a number of the agents now approved to treat lymphoma — including 131I-tosituomab/tositumomab, bortezomib, and pralatrexate — and through clinical studies I am evaluating the benefits of novel combinations of agents. In another area of research I am working to improve the prognostic value of patients’ pathology specimens using computer-aided image analysis. I have published more than 100 papers on lymphoma research in journals such as Blood, Journal of Clinical Oncology, and Clinical Cancer Research.

I am involved in several national organizations that provide information about lymphoma treatment and fund laboratory and clinical research. I am chairperson of the Non-Hodgkin Lymphoma Guidelines panel of the National Comprehensive Cancer Network and vice chairperson of the Lymphoma Core Committee of the Cancer and Leukemia Group B. I am also a member of the scientific advisory board of the Lymphoma Research Foundation.

Appointments for New Patients
Clinical Expertise

Hodgkin and non-Hodgkin Lymphomas: Lymphocytic Lymphomas, Diffuse Large B Cell Lymphoma, Mantle Cell Lymphoma; Chronic Lymphocytic Leukemia; Immunotherapy for Lymphoma

Languages Spoken

MD, Harvard Medical School


Stanford University Medical Center


Stanford University Medical Center

Board Certifications

Internal Medicine; Medical Oncology

Publications by Andrew D. Zelenetz
Visit PubMed for full listing of Andrew D. Zelenetz journal articles
Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.